Cargando…

COPD-Arzneien trotz Pandemie beibehalten!

Detalles Bibliográficos
Autor principal: Kreutz, Ingrid
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Medizin 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8370778/
https://www.ncbi.nlm.nih.gov/pubmed/34421464
http://dx.doi.org/10.1007/s11298-021-2100-5
_version_ 1783739505156554752
author Kreutz, Ingrid
author_facet Kreutz, Ingrid
author_sort Kreutz, Ingrid
collection PubMed
description
format Online
Article
Text
id pubmed-8370778
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer Medizin
record_format MEDLINE/PubMed
spelling pubmed-83707782021-08-18 COPD-Arzneien trotz Pandemie beibehalten! Kreutz, Ingrid CME (Berl) Schwerpunkt Springer Medizin 2021-08-24 2021 /pmc/articles/PMC8370778/ /pubmed/34421464 http://dx.doi.org/10.1007/s11298-021-2100-5 Text en © Springer Medizin Verlag GmbH, ein Teil von Springer Nature 2021 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Schwerpunkt
Kreutz, Ingrid
COPD-Arzneien trotz Pandemie beibehalten!
title COPD-Arzneien trotz Pandemie beibehalten!
title_full COPD-Arzneien trotz Pandemie beibehalten!
title_fullStr COPD-Arzneien trotz Pandemie beibehalten!
title_full_unstemmed COPD-Arzneien trotz Pandemie beibehalten!
title_short COPD-Arzneien trotz Pandemie beibehalten!
title_sort copd-arzneien trotz pandemie beibehalten!
topic Schwerpunkt
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8370778/
https://www.ncbi.nlm.nih.gov/pubmed/34421464
http://dx.doi.org/10.1007/s11298-021-2100-5
work_keys_str_mv AT kreutzingrid copdarzneientrotzpandemiebeibehalten